Abstract
FŒTAL bradycardia during labour is usually taken to be a sign of ‘fœtal distress’, its occurrence being interpreted as a consequence of fœtal hypoxia. Beard1 has recently considered the possibility of an endogenous humoral agent such as noradrenaline in the maternal circulation contributing to, or causing, this type of fœtal response. After injecting noradrenaline into the pregnant human subject, he noted a transitory fœtal bradycardia but was not able to decide from his results whether this effect stemmed from uterine vasoconstriction with subsequent fœtal hypoxia or from a direct action of noradrenaline on the fœtal cardiovascular system.
Similar content being viewed by others
Article PDF
References
Beard, R. W., Brit. Med. J., i, 443 (1962).
Weil-Malherbe, H., Meth. Med. Res., 9, 130 (1961).
Karlberg, P., Moore, R. E., and Oliver, T. K., Acta Paediat., 51, 284 (1962).
Axelrod, J., Pharmacol. Rev., 11, 402 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SANDLER, M., RUTHVEN, C., CONTRACTOR, S. et al. Transmission of Noradrenaline across the Human Placenta. Nature 197, 598 (1963). https://doi.org/10.1038/197598a0
Issue Date:
DOI: https://doi.org/10.1038/197598a0
This article is cited by
-
The Placental Barrier: the Gate and the Fate in Drug Distribution
Pharmaceutical Research (2018)
-
Developmental changes in the activity of catechol-O-methyl transferase in rat and rabbit fetuses
Journal of Neural Transmission (1979)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.